Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Not all psychedelics are created equal

Psychedelics act on multiple receptors beyond 5-HT2A, but their contribution to subjective and behavioral effects is poorly defined. A receptor-informed, neuroimaging-integrated framework can better capture this complexity and guide more-personalized, mechanism-based psychedelic therapies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Binding affinities and phenomenological effects of various serotonergic psychedelics.
Fig. 2: Three steps of a comparative neuroimaging approach.

References

  1. Nutt, D., Spriggs, M. & Erritzoe, D. Neuropharmacology 223, 109257 (2023).

    Article  PubMed  Google Scholar 

  2. Kwan, A. C., Olson, D. E., Preller, K. H. & Roth, B. L. Nat. Neurosci. 25, 1407–1419 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Strassman, R. J. Behav. Brain Res. 73, 121–124 (1996).

    Article  PubMed  Google Scholar 

  4. Pokorny, T., Preller, K. H., Kraehenmann, R. & Vollenweider, F. X. Eur. Neuropsychopharmacol. 26, 756–766 (2016).

    Article  PubMed  Google Scholar 

  5. Becker, A. M. et al. Clin. Pharmacol. Ther. 117, 1784–1792 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Moliner, R. et al. Nat. Neurosci. 26, 1032–1041 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Jain, M. K. et al. Neuron 113, 3129–3142.e9 (2025).

    Article  PubMed  Google Scholar 

  8. Preller, K. H. et al. Proc. Natl Acad. Sci. USA 116, 2743–2748 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Olson, D. E. J. Exp. Neurosci. 12, 1179069518800508 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Avram, M. et al. Mol. Psychiatry 30, 1297–1307 (2025).

    Article  PubMed  Google Scholar 

  11. Mallaroni, P., Singleton, P., Mason, N. L., Sattertwhaite, T. D. & Ramaekers, J. G. Preprint at bioRxiv https://doi.org/10.1101/2024.10.22.619393 (2024).

  12. Ray, T. S. PLoS ONE 5, e9019 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  13. Vogt, S. B. et al. Transl. Psychiatry 13, 172 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ley, L. et al. Neuropsychopharmacology 48, 1659–1667 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Uthaug, M. V. et al. Psychopharmacology 237, 773–785 (2020).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the conception of this Comment, participated in writing and editing the manuscript, and approved the final version of the text.

Corresponding authors

Correspondence to Johannes G. Ramaekers or Mihai Avram.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ramaekers, J.G., Mallaroni, P., Mason, N.L. et al. Not all psychedelics are created equal. Nat. Mental Health 3, 1465–1467 (2025). https://doi.org/10.1038/s44220-025-00551-y

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s44220-025-00551-y

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing